Stock futures inched down Monday morning ahead of a critical meeting in Washington between President Donald Trump and Ukrainian President Volodymyr Zelensky, with investors also eyeing the Federal Reserve’s interest rate path as minutes from the July meeting and a key speech by Chair Jerome Powell later this week take center stage.
Here are some of Monday’s biggest stock movers:
Biggest stock gainers
- Soho House (NYSE:SHCO) +16% – Shares rallied after reports surfaced that the company is nearing a $1.8B go-private deal (ex-debt). As per the reports, an investor group led by MCR Hotels is acquiring the firm for $9/share, a ~18% premium to Friday’s close. Apollo Global (APO) is said to provide $700M+ in financing, while controlling shareholder Ron Burkle and others will roll over stakes. The move follows pressure from activist Dan Loeb’s Third Point, with final terms expected this week.
- Dayforce (NYSE:DAY) +13% – Shares jumped after Bloomberg reported that Thoma Bravo is in advanced talks to acquire the HR software provider in a deal that could be announced in the coming weeks, though discussions may still falter or draw rival bids. Dayforce, which has slipped ~5% over the past year and holds a market value of ~$8.4B with ~$1.2B debt (enterprise value >$9B), could become the private equity firm’s latest tech buyout after recent deals including Boeing’s $10.6B flight-navigation assets and a $2B purchase of Olo, while it has also been linked to Verint Systems.
-
Novo Nordisk (NVO) +3% – Shares gained after the FDA granted accelerated approval for Wegovy to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition. The decision expands Wegovy’s U.S. indications and follows positive Phase 3 data from the ESSENCE trial. The approval provides a boost for Novo, which recently lost more than one-third of its market value following a profit warning and leadership change.